| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Other comprehensive income (loss) | -1,720 | 4,036 | 198 | 1,378 |
| Comprehensive income (loss) | -3,796 | 2,901 | -2,132 | 3,205 |
| Earnings per share, basic, total | -0.03 | -0.02 | -0.04 | 0.03 |
| Earnings per share, diluted, total | -0.03 | -0.02 | -0.04 | -0.01 |
| Weighted average number of shares outstanding, basic, total | 63,865,571 | 63,865,571 | 63,865,571 | 63,865,571 |
| Weighted average number of shares outstanding, diluted, total | 63,865,571 | 63,865,571 | 63,865,571 | 162,726,685 |
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)